The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge

被引：35
|
作者：
Temian, Daiana Cosmina [1 ,2 ]
Pop, Laura Ancuta [1 ]
Irimie, Alexandra Iulia [3 ]
Berindan-Neagoe, Ioana [1 ,4 ,5 ]
机构：
[1] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Prosthet Dent & Dent Mat, Div Dent Propaedeut, Aesthet, 23 Marinescu St, Cluj Napoca 40015, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, MedFUTURE Res Ctr Adv Med, Cluj Napoca, Romania
[5] Oncol Inst Prof Dr I Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania
来源：
JOURNAL OF BREAST CANCER | 2018年 / 21卷 / 03期
关键词：
Breast neoplasms; DNA methylation; Histone code; Triple negative breast neoplasms; Untranslated RNA; LONG NONCODING RNAS; HISTONE DEACETYLASE INHIBITORS; PREDICTS SENSITIVITY; MOLECULAR PORTRAITS; DOWN-REGULATION; AXON GUIDANCE; MUTANT P53; EXPRESSION; IDENTIFICATION; BROMODOMAIN;
D O I：
10.4048/jbc.2018.21.e41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer has the highest incidence among all malignancies diagnosed in women. Therapies have significantly improved over the years due to extensive molecular and clinical research; in a large number of cases, targeted therapies have provided better prognosis. However, one specific subtype remains elusive to targeted therapies-the triple-negative breast cancer. This immunohistochemically defined subtype is resistant to both endocrine and targeted therapies, leading to its poor prognosis. A field that is of great promise in current cancer research is epigenetics. By studying the epigenetic mechanisms underlying tumorigenesis-DNA methylation, histone modifications, and noncoding RNAs-advances in cancer treatment, diagnosis, and prevention are possible. This review aims to synthesize the epigenetic discoveries that have been made related to the triple-negative breast cancer.
引用
收藏
页码：233 / +
页数：16
相关论文
共 50 条
  • [31] Immunohistochemical Characteristics of Triple Negative/Basal-like Breast Cancer
    Pala, Emel Ebru
    Bayol, Umit
    Cumurcu, Suheyla
    Keskin, Elif
    TURKISH JOURNAL OF PATHOLOGY, 2012, 28 (03) : 238 - 244
  • [32] Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles
    Gazinska, Patrycja
    Grigoriadis, Anita
    Brown, John P.
    Millis, Rosemary R.
    Mera, Anca
    Gillett, Cheryl E.
    Holmberg, Lars H.
    Tutt, Andrew N.
    Pinder, Sarah E.
    MODERN PATHOLOGY, 2013, 26 (07) : 955 - 966
  • [33] Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
    S E Elsheikh
    A R Green
    E A Rakha
    R M Samaka
    A A Ammar
    D Powe
    J S Reis-Filho
    I O Ellis
    British Journal of Cancer, 2008, 99 : 327 - 334
  • [34] Challenging Clinical Scenarios: Treatment of Patients With Triple-Negative or Basal-Like Metastatic Breast Cancer
    Greenberg, Sally
    Rugo, Hope S.
    CLINICAL BREAST CANCER, 2010, 10 : S20 - S29
  • [35] VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer
    Angeles Castilla, Maria
    Angeles Lopez-Garcia, Maria
    Reina Atienza, Maria
    Manuel Rosa-Rosa, Juan
    Diaz-Martin, Juan
    Luisa Pecero, Maria
    Vieites, Begona
    Romero-Perez, Laura
    Benitez, Javier
    Calcabrini, Annarica
    Palacios, Jose
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : 587 - 599
  • [36] Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
    Elsheikh, S. E.
    Green, A. R.
    Rakha, E. A.
    Samaka, R. M.
    Ammar, A. A.
    Powe, D.
    Reis-Filho, J. S.
    Ellis, I. O.
    BRITISH JOURNAL OF CANCER, 2008, 99 (02) : 327 - 334
  • [37] FOXC1 expression is associated with a triple-negative basal-like phenotype in breast cancer
    Cho, William C.
    Ma, Victor W.
    Cheuk, Wah
    So, Grace Y.
    Chin, Rebecca Y.
    CANCER RESEARCH, 2020, 80 (16)
  • [38] c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer
    Ren, Xinyu
    Yuan, Li
    Shen, Songjie
    Wu, Hanwen
    Lu, Junliang
    Liang, Zhiyong
    TUMOR BIOLOGY, 2016, 37 (08) : 11385 - 11395
  • [39] Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
    Anna Niwińska
    Wojciech Olszewski
    Magdalena Murawska
    Katarzyna Pogoda
    Journal of Neuro-Oncology, 2011, 105 : 547 - 553
  • [40] Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer
    Yao, Qian
    Hou, Wei
    Chen, Junbing
    Bai, Yanhua
    Long, Mengping
    Huang, Xiaozheng
    Zhao, Chen
    Zhou, Lixin
    Niu, Dongfeng
    FRONTIERS IN MEDICINE, 2022, 9
12345